This review summarizes the scope, prevention, and management of bleeding complications in patients with non-ST-elevation acute coronary syndromes undergoing antithrombotic therapy and percutaneous interventions.
May inform bleeding mitigation strategies in NSTE-ACS; leaves open optimal regimens pending new trials.
Antithrombotic and antiplatelet drugs and percutaneous interventions have decreased the ischemic outcomes of non-ST-elevation acute coronary syndromes, but they pose risks of bleeding. The authors review the scope of the problem and ways to prevent and manage bleeding in this situation.
No takes yet. Share an insight, caveat, or question.
Gutiérrez et al. (2010) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: